In recent years, mounting evidence has indicated that high expression of sterol O-acyltransferase 1 (SOAT1) is accompanied by high CE content in glioblastoma, pancreatic cancer, prostate cancer, and some other tumors [4,5,6,7]. The gene discussed is SOAT1; the disease is glioblastoma.